Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Dan L Duncan Comprehensive Cancer Center at Baylor St.

Luke's Medical Center is dedicated to delivering high quality, compassionate care to Houston and nearby communities. The Center brings together all of our cancer-related activities under one umbrella, fast-tracking our efforts to prevent and ultimately cure cancer.

Dr. Alastair Thompson shares more about artificial intelligence in breast cancer treatment. https://bit.ly/4svO8GJ
03/09/2026

Dr. Alastair Thompson shares more about artificial intelligence in breast cancer treatment. https://bit.ly/4svO8GJ

The patented technology could help reduce repeat procedures in an estimated 300,000 breast cancer surgeries annually.

Dr. Punam Amin shares what everyone should know about colorectal cancer.
03/04/2026

Dr. Punam Amin shares what everyone should know about colorectal cancer.

Dr. Punam Amin provides important insight about colorectal cancer and debunks common myths about the illness.

Dr. Jeffery Rosen shares what patients need to know about triple negative breast cancer.
03/03/2026

Dr. Jeffery Rosen shares what patients need to know about triple negative breast cancer.

Dr. Jeffrey Rosen discusses the prominence of triple negative breast cancer and how researchers at Baylor College of Medicine are studying the disease.

Take a closer look at a triple-negative breast cancer cell cluster and how it can promote metastasis.
02/27/2026

Take a closer look at a triple-negative breast cancer cell cluster and how it can promote metastasis.

The Image this month shows a mechanism that mediates the formation of breast cancer cell clusters and promotes cancer metastasis.

Dr. Ahmed Elkhanany and others discuss the recent results for a new possible therapy for breast cancer.
02/25/2026

Dr. Ahmed Elkhanany and others discuss the recent results for a new possible therapy for breast cancer.

Elacestrant (Orserdu), in combination with either everolimus (Afinitor) or abemaciclib (Verzenio), improved progression-free survival in patients with ER-positive, HER2-negative metastatic breast cancer, according to updated phase 2 ELEVATE trial data presented at the San Antonio Breast Cancer Sympo...

A ‘sticky situation’ boosts triple negative breast cancer’s ability to metastasize.
02/20/2026

A ‘sticky situation’ boosts triple negative breast cancer’s ability to metastasize.

These finding highlight new possibilities for developing clinical interventions to treat metastatic TNBC patients for whom there are no specific therapies.

Results are in from the first melanoma trial targeting the tumor's microenvironment.
02/18/2026

Results are in from the first melanoma trial targeting the tumor's microenvironment.

Final results from the LOKON003 phase 1/2 trial: LOAd703 may re-sensitize therapy resistant melanoma patients to continued checkpoint antibody treatment.

Dr. Fasiha Kanwal explains how understanding fatty liver disease is key to liver cancer prevention.
02/16/2026

Dr. Fasiha Kanwal explains how understanding fatty liver disease is key to liver cancer prevention.

What is the link between liver disease and liver cancer? Dr. Fasiha Kanwal explains how to reduce your risk.

Baylor Medicine experts share what patients need to know about colorectal cancer prevention like regular screenings, lif...
02/13/2026

Baylor Medicine experts share what patients need to know about colorectal cancer prevention like regular screenings, lifestyle changes and more.

Baylor Medicine experts share what patients need to know about colorectal cancer prevention like regular screenings, lifestyle changes and more.

Researchers find ‘sticky coat’ boosts triple negative breast cancer’s ability to metastasize.
02/11/2026

Researchers find ‘sticky coat’ boosts triple negative breast cancer’s ability to metastasize.

Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize,...

Address

1919 Old Spanish Trail
Houston, TX
77054

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+18329576500

Website

https://www.chistlukeshe

Alerts

Be the first to know and let us send you an email when Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke's Medical Center is dedicated to delivering high quality, compassionate care to Houston, TX and nearby communities. Visit us at 7200 Cambridge St or call (713) 798-2262 for more information. As one of only three NCI-designated Comprehensive Cancer Centers in Texas, the DLDCCC is one of the best in the country and is able to contribute vital advances to cancer research through national funding. Specialized health care providers at the DLDCCC are dedicated to understanding, preventing, and treating this disease.